Second primary in the contralateral breast after treatment of breast cancer.

PURPOSE To study the potential risk factors for contralateral breast cancer (CBC) in women after treatment of the primary breast cancer. PATIENTS AND METHODS Between January 1985 and December 1995, records of 1084 breast cancer patients at our institution were analyzed for incidence of CBC. In all the patients a detailed analysis was carried out with respect to age, disease stage, radiation therapy technique, dose, the use of chemotherapy or hormone therapy, and other clinical and/or pathologic characteristics. The Kaplan-Meier method was used to estimate the acturial rate of CBC. The Cox proportional hazard regression model was used to estimate the relative risk (RR) of CBC. RESULTS Up to December 2005, the median follow up was 12 years. Overall incidence of CBC was 4%. The 10 and 20 year acturial rate of CBC was 5.6% and 11.3%, respectively. The CBC rate at 10 and 20 year was 5.4% and 10.2%, respectively, for patients with mastectomy only and 5.1% and 9.7%, respectively, in the mastectomy plus RT group (p=0.3). In the subset of patients <45 years of age at the time of treatment, 10 and 20 year acturial rate of CBC was 5% and 9%, respectively, for patients who underwent mastectomy only and 6.3% and 11%, respectively, for patients treated with mastectomy plus RT (RR=1.4, 95% CI: 1.14-1.45, p=0.003). There was statistically significant lower rate of CBC in patients given adjuvant hormonal therapy (8.5%) as compared to those without hormonal therapy (14.3%, p=0.004) at 20 year. Women with family history of breast cancer had highest rate (15.3%) of CBC (RR=1.6, 95% CI: 1.12-1.27) at 20 years. The adjuvant use of chemotherapy did not significantly affect the risk of second malignancy. CONCLUSION There seems to be little risk of second malignancies in patients treated with mastectomy plus RT using modern techniques, compared with mastectomy only, that was only prevalent in patients <45 years of age. Family history of breast cancer seems to be the highest risk factor for CBC.

[1]  L. Mariani,et al.  Prognostic factors for metachronous contralateral breast cancer: A comparison of the linear Cox regression model and its artificial neural network extension , 1997, Breast Cancer Research and Treatment.

[2]  Cancer in the contralateral breast after radiotherapy for breast cancer. , 1992, The New England journal of medicine.

[3]  Thompson Wd,et al.  RISK OF CONTRALATERAL BREAST CANCER: ASSOCIATIONS WITH FACTORS RELATED TO INITIAL BREAST CANCER , 1988 .

[4]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[5]  C. Grau,et al.  Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Enstrom,et al.  Contralateral Breast Cancers following Treatment for Initial Breast Cancers in Women , 1989, American journal of clinical oncology.

[7]  J. Evans,et al.  The influence of diagnostic radiography on the incidence of breast cancer and leukemia. , 1986, The New England journal of medicine.

[8]  A. Coldman,et al.  Radiation dose and second breast cancer. , 1985, British Journal of Cancer.

[9]  Bernard Asselain,et al.  Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. , 2007, International journal of radiation oncology, biology, physics.

[10]  B. Haffty,et al.  Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit? , 1999, International journal of radiation oncology, biology, physics.

[11]  M. Hakama,et al.  Risk factors for contralateral breast cancer in Chennai (Madras), India. , 1998, International journal of epidemiology.

[12]  B. Silver,et al.  Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. , 2002, International journal of radiation oncology, biology, physics.

[13]  V. Pompe‐Kirn,et al.  Second primary cancers in breast cancer patients in Slovenia , 1997, Cancer Causes & Control.

[14]  Brinton La,et al.  Second cancer following cancer of the breast in Connecticut, 1935-82. , 1985 .

[15]  A. Hanlon,et al.  Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. , 2000, International journal of radiation oncology, biology, physics.

[16]  E. Cook,et al.  Contralateral breast cancer: clinical characteristics and impact on prognosis. , 1993, Journal of Clinical Oncology.

[17]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[18]  S. Schwartz,et al.  A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States) , 1996, Cancer Causes & Control.

[19]  D. Fischer,et al.  Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Jacobsen,et al.  Adjuvant radiotherapy and risk of contralateral breast cancer. , 1992, Journal of the National Cancer Institute.

[21]  B. Emami,et al.  Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. , 2003, International journal of radiation oncology, biology, physics.

[22]  W. P. Darby,et al.  Radiogenic breast cancer effects of mammographic screening. , 1986, Journal of the National Cancer Institute.

[23]  J. Kurtz,et al.  Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. , 1988, International journal of radiation oncology, biology, physics.

[24]  X. Y. Wang,et al.  Dose to contralateral breast: a comparison of four primary breast irradiation techniques. , 1996, International journal of radiation oncology, biology, physics.

[25]  J. Bailar.  Mammography before age 50 years? , 1988, JAMA.

[26]  H. Brenner,et al.  Second primary neoplasms following breast cancer in Saarland, Germany, 1968-1987. , 1993, European journal of cancer.

[27]  G. Ribeiro,et al.  The Christie Hospital breast conservation trial: an update at 8 years from inception. , 1993, Clinical oncology (Royal College of Radiologists (Great Britain)).

[28]  Thompson Wd.  Methodologic perspectives on the study of multiple primary cancers , 1986 .

[29]  H Kaija,et al.  Tangential breast irradiation with or without internal mammary chain irradiation: results of a randomized trial. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  U. Kalokhe,et al.  Scatter dose from tangential breast irradiation to the uninvolved breast. , 1990, Radiology.

[31]  A. Hanlon,et al.  Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. , 2001, International journal of radiation oncology, biology, physics.

[32]  Sha X. Chang,et al.  A comparison of different intensity modulation treatment techniques for tangential breast irradiation. , 1999, International journal of radiation oncology, biology, physics.

[33]  P. Horn-Ross,et al.  Multiple primary cancers involving the breast. , 1993, Epidemiologic reviews.

[34]  G. Bonadonna,et al.  Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  P. Roberson,et al.  Dose to the contralateral breast due to primary breast irradiation. , 1985, International journal of radiation oncology, biology, physics.

[36]  N. Risch,et al.  Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. , 1992, American journal of epidemiology.

[37]  W. Thompson,et al.  Epidemiology of contralateral breast cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[38]  B. Asselain,et al.  Contralateral breast cancer: annual incidence and risk parameters. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.